首页> 美国卫生研究院文献>Journal of Bacteriology >Evidence for a novel glycinamide ribonucleotide transformylase in Escherichia coli.
【2h】

Evidence for a novel glycinamide ribonucleotide transformylase in Escherichia coli.

机译:大肠杆菌中新型甘氨酰胺核糖核苷酸转化酶的证据。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We demonstrate here that Escherichia coli synthesizes two different glycinamide ribonucleotide (GAR) transformylases, both catalyzing the third step in the purine biosynthetic pathway. One is coded for by the previously described purN gene (GAR transformylase N), and a second, hitherto unknown, enzyme is encoded by the purT gene (GAR transformylase T). Mutants defective in the synthesis of the purN- and the purT-encoded enzymes were isolated. Only strains defective in both genes require an exogenous purine source for growth. Our results suggest that both enzymes may function to ensure normal purine biosynthesis. Determination of GAR transformylase T activity in vitro required formate as the C1 donor. Growth of purN mutants was inhibited by glycine. Under these conditions GAR accumulated. Addition of purine compounds or formate prevented growth inhibition. The regulation of the level of GAR transformylase T is controlled by the PurR protein and hypoxanthine.
机译:我们在这里证明大肠杆菌合成两种不同的甘氨酰胺核糖核苷酸(GAR)转化酶,都催化嘌呤生物合成途径的第三步。一种是由先前描述的purN基因编码的(GAR转化酶N),另一种是迄今未知的酶,是由purT基因编码的(GAR转化酶T)。分离出purN和purT编码的酶的合成有缺陷的突变体。只有两个基因都存在缺陷的菌株才需要外源嘌呤来生长。我们的结果表明,这两种酶都可能起到确保嘌呤生物合成正常的作用。体外测定GAR转化酶T活性需要甲酸酯作为C1供体。 purN突变体的生长受到甘氨酸的抑制。在这些条件下,GAR积累了。嘌呤化合物或甲酸盐的添加阻止了生长抑制。 GAR转化酶T水平的调节受PurR蛋白和次黄嘌呤的控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号